申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0349243A2
公开(公告)日:1990-01-03
The present invention relates to novel ribonucleotide reductase inhibitors and new combinations comprising of an antiviral compound, such as acyclovir, and a thiocarbonohydrazone ribonucleotide reductase inhibitor for the chemotherapeutic treatment or prophylaxis of virus infections, especially viruses of the herpes group.
本发明涉及新型核糖核苷酸还原酶抑制剂以及由抗病毒化合物(如阿昔洛韦)和硫代甲酰腙核糖核苷酸还原酶抑制剂组成的新组合,用于病毒感染,特别是疱疹病毒的化学治疗或预防。